Ultralase acquisition referred to CC

The Office of Fair Trading referred the completed acquisition of Ultralase Ltd by Optimax Clinics Ltd to the Competition Commission in late July over concerns that it could reduce competition for laser eye surgery and could lead to higher prices and reduced quality of service for patients.

You must be a HM Subscriber to view this content.

Subscribe Now »